Sang-Mo Kwon Selected Research

Sang-Mo Kwon Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 01/2012
8	Ischemia 12/2017 - 07/2008
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2013
4	Myocardial Infarction 01/2021 - 01/2011
3	Vascular Diseases (Vascular Disease) 01/2018 - 02/2012
3	Spinal Cord Injuries (Spinal Cord Injury) 05/2013 - 06/2012
3	Lewis Lung Carcinoma 05/2012 - 01/2012
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2016
2	Hypoxia (Hypoxemia) 03/2018 - 08/2016
2	Wounds and Injuries (Trauma) 01/2018 - 10/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 01/2014
2	Bone Fractures (Bone Fracture) 01/2015 - 06/2008
2	Gliosis 12/2012 - 06/2012
2	Carcinogenesis 05/2012 - 01/2012
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Rheumatic Diseases (Rheumatism) 05/2021
1	Eye Diseases (Eye Disease) 05/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Lymphoma (Lymphomas) 02/2018
1	B-Cell Leukemia (Leukemia, B Cell) 02/2018
1	Diabetic Cardiomyopathies 01/2018
1	Inflammation (Inflammations) 10/2016
1	Ovarian Epithelial Carcinoma 08/2016
1	Hyperglycemia 07/2016
1	Atherosclerosis 01/2016
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2015
1	Fibrosis (Cirrhosis) 01/2014
1	Experimental Melanoma 05/2012
1	Adenocarcinoma 05/2012

Drug/Important Bio-Agent (IBA)

9	erucylphosphocholineIBA 03/2018 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2016
2	Protein Disulfide-IsomerasesIBA 01/2022 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021 - 05/2012
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020 - 01/2018
2	Therapeutic UsesIBA 01/2018 - 01/2018
2	CytokinesIBA 01/2014 - 05/2012
2	PhloroglucinolIBA 03/2012 - 01/2012
1	NucleosidesIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Reverse Transcriptase InhibitorsIBA 01/2022
1	etravirine (TMC-125)FDA Link 01/2022
1	A-Form DNA (A-DNA)IBA 12/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2019
1	CateninsIBA 01/2019
1	Dynamins (Dynamin)IBA 03/2018
1	Oxygen (Dioxygen)IBA 03/2018
1	Co-Repressor ProteinsIBA 02/2018
1	Transcription Factors (Transcription Factor)IBA 08/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2016
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 08/2016
1	Glucose (Dextrose)FDA LinkGeneric 07/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	fucoidanIBA 06/2015
1	ursodoxicoltaurineIBA 03/2015
1	MicrogelsIBA 08/2014
1	Angiogenic ProteinsIBA 08/2014
1	GenisteinIBA 01/2014
1	glyceollinIBA 10/2013
1	ginsenoside Rg3IBA 05/2012
1	Green Fluorescent ProteinsIBA 05/2012
1	decursinIBA 05/2012
1	oxidized low density lipoproteinIBA 05/2012
1	IntegrinsIBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	Stem Cell FactorIBA 04/2009
1	Jagged-1 ProteinIBA 07/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2008

Therapy/Procedure

12	Therapeutics 05/2021 - 10/2013
6	Transplantation 01/2020 - 06/2012
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 06/2015
3	Cell Transplantation 01/2020 - 09/2012
1	Injections 08/2014
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2012
1	Radiotherapy 02/2012